Comgest Global Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vipshop
VIPS
|
+$104M |
| 2 |
Infosys
INFY
|
+$19.2M |
| 3 |
Visa
V
|
+$13.7M |
| 4 |
Baidu
BIDU
|
+$7.39M |
| 5 |
Coca-Cola Femsa
KOF
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$70.8M |
| 2 |
Cinemark Holdings
CNK
|
+$53.1M |
| 3 |
NetEase
NTES
|
+$27.6M |
| 4 |
Medtronic
MDT
|
+$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$26.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 41.4% |
| 2 | Technology | 24.85% |
| 3 | Healthcare | 12.81% |
| 4 | Consumer Staples | 9.04% |
| 5 | Consumer Discretionary | 7.26% |
Similar funds
Comgest Global Investors's Q3 2016 Portfolio in Review
As of Q3 2016, Comgest Global Investors held 56 positions worth $3.36B, up 2% from $3.29B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Comgest Global Investors withdrew a net $116M in Q3 2016, closing 6 positions and reducing 17 holdings. Its most notable exit was Cinemark Holdings, an estimated $53.1M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 41% of assets, down from 43% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Comgest Global Investors opened a new position in Allergan plc worth $1.96M.
- Comgest Global Investors's largest Q3 2016 buy was Allergan plc: 8,500 shares worth $1.96M.
- Comgest Global Investors added most to Vipshop in Q3 2016, an estimated $104M increase.
- Comgest Global Investors's biggest Q3 2016 reduction was Nebius Group N.V., cutting an estimated $70.8M.
- Comgest Global Investors fully exited Cinemark Holdings in Q3 2016, selling an estimated $53.1M.
- Comgest Global Investors's ten largest holdings make up 81% of its $3.36B portfolio in Q3 2016.
- Comgest Global Investors opened 2 new positions and closed 6 in Q3 2016.
- Comgest Global Investors's portfolio value rose 2% quarter-over-quarter to $3.36B.
Based on Comgest Global Investors's 13F filing for Q3 2016, filed 10 Nov 2016.